0.00Open9.30Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover629.76%IV89.83%PremiumJan 17, 2025Expiry Date3.12Intrinsic Value100Multiplier10DDays to Expiry6.19Extrinsic Value100Contract SizeAmericanOptions Type-0.4342Delta0.0548Gamma1.36Leverage Ratio-0.1445Theta-0.0020Rho-0.59Eff Leverage0.0045Vega
Kezar Life Sciences Stock Discussion
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet